A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies Conference

Forouzannia, A, Schiller, J, Berlin, J et al. (2004). A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies . 44(1), 111-119. 10.1016/j.lungcan.2003.10.005

cited authors

  • Forouzannia, A; Schiller, J; Berlin, J; Hutson, P; Boothman, D; Storer, B; Wilding, G; Mehta, M

sustainable development goals

authors

date/time interval

  • May 12, 2001 -

publication date

  • April 1, 2004

webpage

keywords

  • BETA-LAPACHONE
  • CANCER
  • HUMAN CARCINOMA-CELLS
  • INHIBITOR
  • INTRAVENOUS TOPOTECAN
  • LUNG
  • Life Sciences & Biomedicine
  • ONCOLOGY-GROUP
  • Oncology
  • POTENTIATION
  • RADIATION
  • REPAIR
  • Respiratory System
  • Science & Technology
  • Topotecan
  • lung cancer
  • phase I
  • radiosensitizers

Location

  • SAN FRANCISCO, CA

Digital Object Identifier (DOI)

Conference

  • 37th Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • ELSEVIER IRELAND LTD

start page

  • 111

end page

  • 119

volume

  • 44

issue

  • 1